Picture of Burcon NutraScience logo

BU Burcon NutraScience News Story

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapMomentum Trap

Burcon's Q2 revenue grows 783%

Overview

Burcon fiscal Q2 revenue grows 783% yr/yr, driven by protein sales

Burcon achieved first commercial production of canola and fava proteins

Outlook

Burcon reaffirms 2025 revenue target of C$1-3 mln

Company expects 2026 revenue to exceed C$10 mln

Burcon sees continued revenue acceleration and margin expansion into 2026

Result Drivers

COMMERCIAL PRODUCTION - Achieved first commercial production of Puratein® C canola protein and FavaPro™ fava protein

CUSTOMER PIPELINE - Burcon advanced its robust customer pipeline with over 200 projects under evaluation

Key Details

MetricBeat/MissActualConsensus Estimate
Q2 EPS-C$0.28
Press Release: ID:nNFC8K35Td For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Burcon NutraScience

See all news